Clinical Trial: Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Parallel Group Randomized Open Blinded End Point Evaluation, Multicentric, Dose Escalation, Phase -II Study Assessing the Safety and Efficacy of Intraarterial (Hepatic) Ex-vivo Cultured Adult Alloge

Brief Summary: This study will evaluate the safety and efficacy of mesenchymal stem cells in patients with cirrhosis of liver. Stem cells will be injected into the hepatic artery. Improvement in various parameters will be observed over 2 years.